These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 19713424

  • 1. Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome.
    Tosi F, Dorizzi R, Castello R, Maffeis C, Spiazzi G, Zoppini G, Muggeo M, Moghetti P.
    Eur J Endocrinol; 2009 Nov; 161(5):737-45. PubMed ID: 19713424
    [Abstract] [Full Text] [Related]

  • 2. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA, Hassan S, Nisar S, Shamas N, Rashid A, Ahmed I, Douhat S, Mudassar S, Jan VM, Rashid F.
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [Abstract] [Full Text] [Related]

  • 3. Total body fat and central fat mass independently predict insulin resistance but not hyperandrogenemia in women with polycystic ovary syndrome.
    Tosi F, Di Sarra D, Kaufman JM, Bonin C, Moretta R, Bonora E, Zanolin E, Moghetti P.
    J Clin Endocrinol Metab; 2015 Feb; 100(2):661-9. PubMed ID: 25393642
    [Abstract] [Full Text] [Related]

  • 4. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
    Kowalska I, Straczkowski M, Nikolajuk A, Adamska A, Karczewska-Kupczewska M, Otziomek E, Wolczynski S, Gorska M.
    Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143
    [Abstract] [Full Text] [Related]

  • 5. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome.
    Alemzadeh R, Kichler J, Calhoun M.
    Eur J Endocrinol; 2010 Jun; 162(6):1093-9. PubMed ID: 20371657
    [Abstract] [Full Text] [Related]

  • 6. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K, Alkan N, Pirimoglu M, Unal O, Turan C.
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [Abstract] [Full Text] [Related]

  • 7. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
    Ezeh U, Pall M, Mathur R, Azziz R.
    Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
    [Abstract] [Full Text] [Related]

  • 8. Plasma levels of pentraxin-3, an inflammatory protein involved in fertility, are reduced in women with polycystic ovary syndrome.
    Tosi F, Di Sarra D, Bonin C, Zambotti F, Dall'Alda M, Fiers T, Kaufman JM, Donati M, Franchi M, Zanolin ME, Bonora E, Moghetti P.
    Eur J Endocrinol; 2014 Mar; 170(3):401-9. PubMed ID: 24347428
    [Abstract] [Full Text] [Related]

  • 9. Body fat composition and distribution in women with polycystic ovary syndrome.
    Cosar E, Uçok K, Akgün L, Köken G, Sahin FK, Arioz DT, Baş O.
    Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
    [Abstract] [Full Text] [Related]

  • 10. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
    Verit FF.
    Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
    [Abstract] [Full Text] [Related]

  • 11. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
    Morrison SA, Goss AM, Azziz R, Raju DA, Gower BA.
    Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
    [Abstract] [Full Text] [Related]

  • 12. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
    Arikan S, Bahceci M, Tuzcu A, Kale E, Gökalp D.
    Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
    [Abstract] [Full Text] [Related]

  • 13. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
    Pinola P, Puukka K, Piltonen TT, Puurunen J, Vanky E, Sundström-Poromaa I, Stener-Victorin E, Lindén Hirschberg A, Ravn P, Skovsager Andersen M, Glintborg D, Mellembakken JR, Ruokonen A, Tapanainen JS, Morin-Papunen LC.
    Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
    [Abstract] [Full Text] [Related]

  • 14. The polycystic ovary syndrome per se is not associated with increased chronic inflammation.
    Möhlig M, Spranger J, Osterhoff M, Ristow M, Pfeiffer AF, Schill T, Schlösser HW, Brabant G, Schöfl C.
    Eur J Endocrinol; 2004 Apr; 150(4):525-32. PubMed ID: 15080783
    [Abstract] [Full Text] [Related]

  • 15. Serum complement C3 has a stronger association with insulin resistance than high-sensitivity C-reactive protein in women with polycystic ovary syndrome.
    Yang S, Li Q, Song Y, Tian B, Cheng Q, Qing H, Zhong L, Xia W.
    Fertil Steril; 2011 Apr; 95(5):1749-53. PubMed ID: 21316661
    [Abstract] [Full Text] [Related]

  • 16. Serum C-reactive protein (CRP) levels and insulin resistance in non-obese women with polycystic ovarian syndrome, and effect of bicalutamide on hirsutism, CRP levels and insulin resistance.
    Bahceci M, Tuzcu A, Canoruc N, Tuzun Y, Kidir V, Aslan C.
    Horm Res; 2004 Apr; 62(6):283-7. PubMed ID: 15542929
    [Abstract] [Full Text] [Related]

  • 17. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E, Coulson R, Dunstan F, Evans WD, Blundell HL, Luzio SD, Dunseath G, Halcox JP, Fraser AG, Rees DA.
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [Abstract] [Full Text] [Related]

  • 18. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
    Möhlig M, Weickert MO, Ghadamgadai E, Machlitt A, Pfüller B, Arafat AM, Pfeiffer AF, Schöfl C.
    Eur J Endocrinol; 2007 Aug; 157(2):195-200. PubMed ID: 17656598
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism.
    Hahn S, Backhaus M, Broecker-Preuss M, Tan S, Dietz T, Kimmig R, Schmidt M, Mann K, Janssen OE.
    Eur J Endocrinol; 2007 Aug; 157(2):201-7. PubMed ID: 17656599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.